Effects of ethane-1 hydroxy-1, 1-Diphosphonate (5 mg/kg/day dose) onquantitative bone histology in paget's disease of bone
- 31 December 1981
- journal article
- Published by Elsevier in Metabolic Bone Disease and Related Research
- Vol. 3 (4-5) , 309-315
- https://doi.org/10.1016/0221-8747(81)90047-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment of Paget's disease with combined calcitonin and diphosphonate (EHDP)Metabolic Bone Disease and Related Research, 1978
- Sodium Etidronate in the Treatment of Paget's Disease of BoneAnnals of Internal Medicine, 1977
- Diphosphonate Therapy of Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1977
- Quantitative bone histology in paget's disease of bone: Influence of sodium etidornate (EHDP) therapyCalcified Tissue International, 1976
- PAGET'S BONE DISEASE TREATED WITH DIPHOSPHONATE AND CALCITONINThe Lancet, 1976
- Treatment of Paget Disease of Bone (Osteitis Deformans)Published by American Medical Association (AMA) ,1974
- Influence of Disodium Etidronate on Clinical and Laboratory Manifestations of Paget's Disease of Bone (Osteitis Deformans)New England Journal of Medicine, 1973
- The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystalsCalcified Tissue International, 1973
- Tetracycline-based histological analysis of bone remodelingCalcified Tissue International, 1969
- Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivoScience, 1969